secwatch.observer — SEC 8-K summary
======================================

Issuer:     RESMED INC (RMD)
CIK:        0000943819
Form:       8-K/A
Filed at:   2022-08-12T23:59:59+00:00
Accession:  0001193125-22-218896
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.75
Item codes: 8.01, 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ResMed to acquire MediFox-Dan for EUR 810M; closing expected by Dec 31, 2022
----------------------------------------------------------------------------

- Base purchase price of EUR 810M fixed via locked box; enterprise value EUR 950M.
- Funded with existing cash and borrowings under credit facility; intercompany loan to ResMed Germany SaaS.
- Closing subject to German merger control, foreign investment, and BaFin clearances.
- Termination fee of EUR 10M payable to seller if BaFin clearance not obtained.
- Acquisition of 100% of MediFox-Dan shares and shareholder loan receivables.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/943819/000119312522218896/0001193125-22-218896-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/943819/000119312522218896/d387047d8ka.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-218896

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer